Results

Total Results: 937 records

Showing results for "question".

201. Screening and Behavioral Counseling Interventions to Reduce Alcohol Use in Adolescents and Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/m_E9nFrmxuS5-surqVHK2u
     November 13, 2018 - Benefits of Screening Key Question 1a. … Key Question 1b. … Key Question 2. … Harms of Screening Key Question 3. … Harms of Interventions Key Question 5.

202. Archived: Evidence Summary: Visual Impairment in Children Ages 1-5: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary5/visual-impairment-in-children-ages-1-5-screening-2011
     January 15, 2011 - We assessed the overall strength of the body of evidence for each key question (good, fair, or poor) … Key Question 1a: Does Effectiveness of Vision Screening in Children Aged 1 to 5 Years Vary in Different … Key Question 3: What Is the Accuracy of Screening Tests for Vision Impairment in Children Aged 1 to 5 … Key Question 3a: In Children Aged 1 to 5 Years, Does Accuracy of Screening Tests for Vision Impairment … Key Question 5: What Is the Effectiveness of Treatment for Vision Impairment in Children Aged 1 to 5

203. Sbmxphuqwo-Dc85Fj5Whf (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SBmXPhUQWo-dc85FJ5wHf
     February 01, 2015 - BP (key questions 1 and 5, respectively), diagnostic ac- curacy of office BP measurement (OBPM) (key question … prediction of cardiovascular events by BP method and diagnostic accuracy of nonoffice measurement (key question … 3), and rescreening interval (key question 4). … –1.20) 1.13 (1.08–1.19) 1.09 (0.92–1.29) HR (95% CI) 210.5 Results of included studies for key question … Overall Summary of Evidence, by Key Question Key Question Studies, n Overall Quality Limitation Consistency

204. Archived: Final Evidence Summary: Chlamydial Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary14/chlamydial-infection-screening-2007
     June 15, 2007 - Study Selection For key question 1, the review was limited to randomized, controlled trials of nonpregnant … Key Question 2 Does screening for chlamydial infection in pregnant women reduce adverse health outcomes … Key Question 3 Does screening for chlamydial infection reduce adverse health outcomes in men, reduce … Articles reviewed during the critical key question reviews were tagged if they addressed a subsidiary … key question.

205. Archived: Evidence Summary: Syphilis Infection in Pregnant Women: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/syphilis-infection-in-pregnancy-screening-september-2018
     September 04, 2018 - Benefits of Screening Key Question … Harms of Screening Key Question 2. … Harms of Treatment Key Question 3. … benefit of penicillin G for the treatment of syphilis is well established, so new evidence for this question … Diagram KQ indicates key question

206. Final Research Plan: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/brca-related-cancer-risk-assessment-genetic-counseling-testing
     April 11, 2024 - Additionally, Contextual Question 1 is designed to address other important health equity considerations … Food and Drug Administration; KQ = Key Question.

207. Archived: Evidence Summary: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary8/abdominal-aortic-aneurysm-screening-2014
     January 15, 2014 - For the key question examining the harms of screening for AAAs, we considered RCTs and observational … Data Synthesis and Analysis We qualitatively synthesized data for each key question by summarizing … AAA = abdominal aortic aneurysm; KQ = key question … Twelve articles were included for Key Question 1, 11 for Key Question 2, 7 for Key Question 3, 21 for … Key Question 4, and 17 for Key Question 5.

208. Clinical Summary: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/y3mQMyN2Y8mxKvPPXjM6kV
     History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question

209. Final Research Plan: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-serologic-screening
     December 02, 2021 - Abbreviations: HSV=herpes simplex virus; KQ=key question. … Food and Drug Administration; HIV=human immunodeficiency virus; HSV=herpes simplex virus; KQ=key question

210. Evidence Summary: Food Insecurity: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/food-insecurity-screening
     March 11, 2025 - Accuracy of Screening Instruments Key Question 2. … screener being administered independently from the reference standard. 19 Assessment Harms Key Question … Intervention Benefits Key Question 4. … Intervention Harms Key Question 5. … American Academy of Pediatrics; HFSS, Household Food Security Survey; HVS, Hunger Vital Sign; KQ, key question

211. Final Evidence Summary: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
     June 09, 2020 - Benefits of Screening Key Question 1. … Harms of Screening Key Question 3. … Benefits of Interventions Key Question 4. … Harms of Interventions Key Question 5. … Harms of Naloxone Preemptive Prescribing Key Question 7.

212. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghbfx9e3A6jQEqVW26y8Jv
     March 09, 2021 - Key Question 1b. … Key Question 1c. … Key Question 1d. … Key Question 3b. … Key Question 3c.

213. Draft Research Plan: Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
     February 01, 2024 - Alcohol, and other Drugs (BSTAD) or comparable Studies without any screening instruments or question … to design-specific USPSTF criteria) Abbreviations: DUI=driving under the influence; KQ=key question

214. Screening, Referral, Behavioral Counseling, and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9AtjNaSwTXonz49w_DEbNz
     November 07, 2023 - Key Question 2a. … Key Question 2b. … Key Question 3. … Key Question 2. … Key Question 3.

215. Skin Cancer Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/wKfFrTpC8VtforKLrqGpjQ
     April 18, 2023 - results and contextual issues are available in the full evidence report.10 Benefits of Screening Key Question … Association Between Screening and Stage at Detection Key Question 2. … 8-month follow-up assessments.35,36 Association Between Stage at Detection and Health Outcomes Key Question … Summary of Evidence by Key Question No. of studies Summary of findings Consistency and precision Overall … Summary of Evidence by Key Question (continued) No. of studies Summary of findings Consistency and precision

216. Evidence Summary: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-anxiety-children-adolescents
     October 11, 2022 - Benefits of Screening Key Question 1 . … Accuracy of Screening Instruments Key Question 2 . … Harms of Screening Key Question 3 . … Benefits of Treatment Key Question 4 . … KQ indicates key question. a Combined searches were conducted on anxiety, depression, and suicide risk

217. Draft Research Plan: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/syphilis-infection-pregnant-persons
     December 01, 2022 - Study Quality Good- or fair-quality studies Poor-quality studies Abbreviation: KQ = key question

218. Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: A Targeted Evidence Update for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CVoJ9fc9nv2Zsgs8R8XabH
     September 01, 2022 - 12 Key Question 2. … ....................... 13 Key Question 3. … Key Question 1. … Key Question 2. … * Question around the diagnostic accuracy were not addressed in this review.

219. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
     June 09, 2020 - Benefits of Screening Key Question 1. … Harms of Screening Key Question 3. … Benefits of Interventions Key Question 4. … Harms of Interventions Key Question 5. … Harms of Naloxone Preemptive Prescribing Key Question 7.

220. Draft Research Plan: Human Immunodeficiency Virus (HIV): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/human-immunodeficiency-virus-hiv-infection-pregnant-nonpregnant-adults
     November 30, 2023 - EFV = efavirenz; EVG = elvitegravir; EVG/c = elvitegravir/cobicistat; FTC = emtricitabine; KQ = Key Question … ritonavir; DTG = dolutegravir; FTC = emtricitabine; INSTI = integrase strand transfer inhibitor; KQ = Key Question